Description
Cinalukast is a selective Leukotriene D4 receptor antagonist originated by Roche and IC 50 value is 6.4 nM. Cinalukast inhibits the actions of Leukotriene D4 at the CysLT1 receptor and it can prevent airway edema, smooth muscle contraction, and enhanced secretion of thick, viscous mucus. Treatment for Asthma was discontinued